Notice of Effectiveness (effect)
26 Dezember 2018 - 12:01PM
Edgar (US Regulatory)
UNITED STATES
|
SECURITIES AND EXCHANGE COMMISSION
|
Washington, D.C. 20549
|
NOTICE OF EFFECTIVENESS
|
|
Effective Date:
|
December 21,
2018
|
Accession Number:
|
0001193125-18-348294
|
Submission Type:
|
POS AM
|
CIK:
|
0001114220
|
Company Name:
|
KERYX BIOPHARMACEUTICALS INC
|
File Number:
|
333-113654
|
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
Von Dez 2023 bis Dez 2024
Echtzeit-Nachrichten über Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ): 0 Nachrichtenartikel
Weitere Keryx Biopharmaceuticals Inc News-Artikel